381 related articles for article (PubMed ID: 15965157)
1. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
[TBL] [Abstract][Full Text] [Related]
2. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
3. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
4. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
5. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee KW; Lip GY; Blann AD
Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
[TBL] [Abstract][Full Text] [Related]
6. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
[TBL] [Abstract][Full Text] [Related]
7. Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Caine GJ; Stonelake PS; Lip GY; Blann AD
Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
[TBL] [Abstract][Full Text] [Related]
9. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY
Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Lim HS; Lip GY; Blann AD
Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
[TBL] [Abstract][Full Text] [Related]
11. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.
Serefhanoglu S; Goker H; Buyukasik Y; Turgut M; Sayinalp N; Haznedaroglu IC; Aksu S; Akman U; Ozcebe OI
Ann Hematol; 2009 Jul; 88(7):667-71. PubMed ID: 19082594
[TBL] [Abstract][Full Text] [Related]
12. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
Caine GJ; Ryan P; Lip GY; Blann AD
Cancer Lett; 2007 Jun; 251(2):296-301. PubMed ID: 17240049
[TBL] [Abstract][Full Text] [Related]
13. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
Freestone B; Chong AY; Lim HS; Blann A; Lip GY
Ann Med; 2005; 37(5):365-72. PubMed ID: 16179272
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease.
Duits AJ; Rodriguez T; Schnog JJ;
Br J Haematol; 2006 Jul; 134(1):116-9. PubMed ID: 16803577
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
[TBL] [Abstract][Full Text] [Related]
18. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
Cai J; Ruan Q; Chen ZJ; Han S
Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
[TBL] [Abstract][Full Text] [Related]
19. The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients.
van der Heijden M; van Nieuw Amerongen GP; van Hinsbergh VW; Groeneveld AB
Shock; 2010 Mar; 33(3):263-8. PubMed ID: 19543148
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers.
Niedźwiecki S; Stepień T; Kopeć K; Kuzdak K; Komorowski J; Krupiński R; Stepień H
Cytokine; 2006 Dec; 36(5-6):291-5. PubMed ID: 17374490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
